Genetic Screening for the LRRK2 R1441C and G2019S Mutations in Parkinsonian Patients from Campania

Abstract

The R1441C prevalence was higher than that of G2019S (2.5% vs 0.8%), underlining the importance of the geographical differencies in LRRK2 mutation frequency for molecular screening and genetic counseling of PD patients.